Sema4D expression in PBMCs of ALL and AML patients and BMMCs of ALL patients was not correlated with risk classification, early remission status, extramedullary infiltration, chromosome translocation, and fusion genes (Tables S2-4). The gene discussed is SEMA4D; the disease is acute myeloid leukemia.